AzTrials
AzTrials

Femoral Neck FracturesNCT07346885

Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery

A study testing Lumbar and Sacral Plexus Block and Fascia Iliaca Block Combined with Low-Dose Spinal Anesthesia in people with Femoral Neck Fractures and Nerve Block, run by Bursa Yuksek Ihtisas Training and Research Hospital at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

Femoral neck fracture surgery in elderly patients is frequently complicated by intraoperative hypotension and inadequate postoperative analgesia. Regional anesthesia techniques are increasingly preferred to reduce hemodynamic instability and improve pain control. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Femoral Neck Fractures, Nerve Block
What is being tested?
Lumbar and Sacral Plexus Block and Fascia Iliaca Block Combined with Low-Dose Spinal Anesthesia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Dec 2025to 1 Nov 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ->18 years and <90 years
  • American Society of Anesthesiologists score between I and IV
  • Patients who will undergo femoral neck fracture surgery

Who cannot join

  • Previous local anesthetic allergy
  • Those with bleeding diathesis disorder
  • Having a mental disorder
  • Those who are allergic to the drugs used
  • Patients who did not consent to participate in the study
  • Presence of infection in the block area
Show all 10Show fewer
  • Body mass index >30
  • Preoperative or intraoperative general anesthesia
  • Patients for whom consent cannot be obtained
  • Pregnant patients

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • University of Health Sciences,,Bursa Yuksek Ihtisas Training and Research Hospital,

    Bursa

Other trials in Turkey (Türkiye)

About this study

Official title: A Comparison of the Efficacy of Lumbar and Sacral Plexus Block Versus Fascia Iliaca Block Combined With Low-Dose Spinal Anesthesia in Patients Undergoing Surgery for a Femoral Neck Fracture

Femoral neck fracture surgery in elderly patients is frequently complicated by intraoperative hypotension and inadequate postoperative analgesia. Regional anesthesia techniques are increasingly preferred to reduce hemodynamic instability and improve pain control. This prospective observational study aims to compare the efficacy of lumbar and sacral plexus block with fascia iliaca block combined with low-dose spinal anesthesia in terms of severe intraoperative hypotension and postoperative analgesic outcomes in patients undergoing surgery for femoral neck fracture.

Read the detailed description

The global incidence of hip fractures continues to rise, and most patients require surgical intervention. Due to advanced age, frailty, and multiple comorbidities, anesthetic management in this population is particularly challenging. Intraoperative hypotension has been shown to be associated with increased short- and long-term mortality, regardless of the anesthetic technique used.

To reduce the incidence of hypotension, various neuraxial and peripheral nerve block techniques have been investigated. While spinal anesthesia provides reliable surgical conditions, it may still cause significant hypotension. Peripheral nerve blocks, such as lumbar and sacral plexus blocks or fascia iliaca block, tend to preserve hemodynamic stability and are associated with a lower incidence of motor blockade.

Recently, combined techniques using low-dose spinal anesthesia together with fascial plane blocks have been introduced to balance the advantages of neuraxial anesthesia and peripheral nerve blocks. However, there is still no consensus on the optimal regional anesthesia strategy to minimize severe hypotension while ensuring effective analgesia in patients undergoing femoral neck fracture surgery.

Being tested
Lumbar and Sacral Plexus Block, Fascia Iliaca Block Combined with Low-Dose Spinal Anesthesia
Medical subject headings
Femoral Neck Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lumbar and Sacral Plexus BlockProcedure or surgery

    For lumbar and sacral plexus blocks, a 10-15 cm ultrasound-visible peripheral nerve block needle and a nerve stimulator will be used. For lumbar plexus shamrock imaging and sacral plexus blocks, parasacral imaging will be used. 0.5% bupivacaine will be used as the local anesthetic.

  • Fascia Iliaca Block Combined with Low-Dose Spinal AnesthesiaProcedure or surgery

    Spinal anesthesia will be administered using a 25-gauge Quincke needle. After positioning the patient on the side to be operated on in a lateral position, hypobaric spinal anesthesia will be administered through an appropriate (L3-4 or L4-5) with 1.5 cc of local anesthetic mixture. Before receiving spinal anesthesia, patients will undergo a supra-inguinal fascia iliaca block with 20 to 30 milliliters of 0.25% local anesthetic (bupivacaine).

Study groups in NCT07346885
Study groupRoleWhat they receive
Lumbar and Sacral Plexus Block GroupActive comparatorPatients will receive combined lumbar and sacral plexus blocks as the primary regional anesthesia technique for femoral neck fracture surgery, performed by the attending anesthesiologist according to institutional practice.
Receives: Procedure: Lumbar and Sacral Plexus Block
Fascia Iliaca Block Combined with Low-Dose Spinal Anesthesia GroupActive comparatorPatients will receive low-dose spinal anesthesia combined with a supra-inguinal fascia iliaca block for surgical anesthesia and postoperative analgesia.
Receives: Procedure: Fascia Iliaca Block Combined with Low-Dose Spinal Anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Severe Intraoperative Hypotension

    Severe hypotension defined as mean arterial pressure (MAP) < 65 mmHg lasting longer than 12 minutes during surgery

    Measured: Intraoperative period

Secondary outcomes (6)
  1. intraoperative haemodynamic parameters

    non-invasive systolic, diastolic and mean arterial pressure

    mean arterial pressure (mm/hg)

    Measured: intraoperative 2 hours

  2. Total Intraoperative Sedative and Analgesic Drug Consumption

    Total intraoperative sedative and analgesic drug consumption will be recorded, including the cumulative dose of sedative agents (e.g., propofol, midazolam) and analgesic agents (e.g., fentanyl or equivalent opioids) administered during surgery.

    Measured: intraoperative 2 hours

  3. Estimated Intraoperative Blood Loss (mL)

    Estimated intraoperative blood loss will be assessed by the anesthesiology team based on suction canister volume minus irrigation fluids and surgical sponge weight estimation, as routinely used in clinical practice.

    Measured: intraoperative 2 hours

  4. Postoperative Pain Intensity Assessed by the Numeric Rating Scale (NRS)

    Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores will be recorded at rest and during movement

    Measured: postoperative 24 hour

  5. Intraoperative Vasopressor Consumption

    Total dose of vasopressors administered

    Measured: Intraoperative period

  6. Length of Hospital Stay (days)

    Length of hospital stay will be defined as the number of days from the day of surgery until hospital discharge.

    Measured: From the day of surgery through hospital discharge (up to 30 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2026
  2. Study start30 Dec 2025
  3. Primary completion1 Jul 2026
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07346885
Sponsor's protocol ID
TBEK 2025/12-14
Status last verified
Oct 2026
First submitted
29 Dec 2025
Last updated
14 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in